Huasen Pharmaceuticals (002907.SZ): Becomes Marketing Authorization Holder of Clopidogrel Bisulfate Tablets

Zhito Finance APP News: Huasen Pharmaceutical (002907.SZ) announced that the company completed the change of the "Drug Production License" for Clopidogrel Bisulfate Tablets in July 2026, and recently received the "Drug Supplementary Application Approval Notice" for the product approved and issued by the National Medical Products Administration, marking that the product has completed the change of the marketing authorization holder, and the company has become its marketing authorization holder.